NEW YORK, Sept. 4 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. , a medical device company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that its President and CEO Eamonn P. Hobbs will make a presentation to investors at the Rodman & Renshaw 11th Annual Healthcare Conference on Friday, September 11 at 9:10 a.m. Eastern Time in New York. Mr. Hobbs will review the Company’s business strategy and historic financial results. A live webcast of the presentation will be available in the investors section of the Company’s web site at www.delcath.com. The webcast also will be archived and accessible for ninety days.
Delcath Systems, Inc.
